Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan Pre-Treatment in CABG
NCT00610350Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in coronary artery disease (CAD), sponsored by Sapienza University of Rome. Started Jan 2005; status: completed.
02
Drugs
levosimendan
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00610350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610350.